Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 9/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5775533 | 0.91 | HDAC8 (0.33) | HDAC4HDAC8PLA2G7PPARAGRIN2B | |
| SCHEMBL5776662 | 0.88 | TRPV1 (0.37) | HDAC4TRPV1HDAC1HDAC2HDAC8 | |
| SCHEMBL5772985 | 0.82 | GSK3B (0.41) | TRPV1HDAC1HDAC2HDAC8S1PR1 | |
| SCHEMBL5907124 | 0.82 | FAAH (0.36) | TRPV1HDAC1HDAC2HDAC8PPARA | |
| SCHEMBL5775722 | 0.80 | GSK3B (0.41) | HDAC4TRPV1HDAC1HDAC2HDAC8 | |
| SCHEMBL5774056 | 0.80 | TRPV1 (0.38) | TRPV1HDAC1HDAC2HDAC8SLC9A5 | |
| SCHEMBL5774478 | 0.79 | HIF1A (0.42) | S1PR1CYP3A4HTR1AHTR2ACYP2C19 | |
| SCHEMBL5777440 | 0.79 | HDAC8 (0.35) | HDAC4HDAC8CYP3A4SMN1; SMN2PLA2G7 | |
| SCHEMBL5775561 | 0.78 | FAAH (0.39) | HDAC4TRPV1HDAC1HDAC2HDAC8 | |
| SCHEMBL5774573 | 0.77 | LMNA (0.40) | TRPV1HDAC1HDAC2HDAC8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7022725-B2 | Isoxazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-04-04 | — | — | US | disclosed |
| US-20040048908-A1 | Isoxazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-11 | — | — | US | disclosed |
| EP-1340749-A1 | ISOXAZOLE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2003-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040048908-A1 | Isoxazole derivatives | GPR119, INSR, IRS1 | HDAC4 497/4885TRPV1 3621/4885HDAC1 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.